BackMedistim ASA Overview

Medistim ASA Receivables

Track Medistim ASA's receivables ($130M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$130.86M
↑ 11.48% YoYΔ $13.48M vs prior year quarter

Peer trimmed avg / median

Loading

Medistim ASA Receivables History

Loading

Medistim ASA vs. peers: Receivables Comparison

Loading

Medistim ASA Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Medistim ASA (0OCD.L) FAQ

Medistim ASA posts a receivables of $130M as of June 2026. That compares with $120M in the prior-year period — up 11.5% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Medistim ASA's receivables was $120M. The latest reading is $130M — a 11.5% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of Medistim ASA's financial statement story. At $130M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 0OCD.L's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Medistim ASA's other metric pages and overview cover the third.